As the HIV/AIDS pandemic enters its third decade in Latin America, not all the news is bad. Large public investments in the treatment and prevention of the disease offer some cautious hopethat the pandemic can be slowed, contained, and made more bearable for those who suffer its effects. Even more important, as Shawn Smallman suggests herein, “the political victory that Brazil and other developing nations won, by asserting their right to produce generic drugs against HIV,” has improved the life chances of the region’s AIDS patients.
July/August
2008
Volume:
41
Number:
1